Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Circulation

• Publication date

  1998-04-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.97.14.1382PMID 9577950
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sphingosine Mediates the Immediate Negative Inotropic Effects of Tumor Necrosis Factor-α in the Adult Mammalian Cardiac Myocyte*

  1997cited by this paper
• Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart

  1996cited by this paper
• Inhibition of myocardial endothelin pathway improves long-term survival in heart failure

  1996cited by this paper
• Basic mechanisms in heart failure: the cytokine hypothesis.

  1996influential reference
• Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death.

  1996cited by this paper
• Presence of double-strand breaks with single-base 3' overhangs in cells undergoing apoptosis but not necrosis

  1996cited by this paper
• Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).

  1996cited by this paper
• Tumor necrosis factor-alpha induces a biphasic effect on myocardial contractility in conscious dogs.

  1996cited by this paper
• Tumor Necrosis Factor-α Induces a Biphasic Effect on Myocardial Contractility in Conscious Dogs

  1996cited by this paper
• Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart.

  1996cited by this paper
• Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration.

  1995cited by this paper
• Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure.

  1995cited by this paper
• Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure.

  1995cited by this paper
• Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure?

  1995cited by this paper
• DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis.

  1995cited by this paper
• Echocardiographic assessment of left ventricular mass and systolic function in mice.

  1995cited by this paper
• Soluble TNF binding proteins modulate the negative inotropic properties of TNF-alpha in vitro.

  1995cited by this paper
• TNF-R55-specific form of human tumor necrosis factor-alpha induces collagenase gene expression by human skin fibroblasts.

  1995cited by this paper
• Differential Regulation of Sphingomyelinase and Ceramidase Activities by Growth Factors and Cytokines

  1995cited by this paper
• Matrix metalloproteinases and cardiovascular disease.

  1995cited by this paper
• Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines.

  1994cited by this paper
• Decrease in left ventricular contractility after tumor necrosis factor-alpha infusion in dogs.

  1994cited by this paper
• c‐Myc induces cellular susceptibility to the cytotoxic action of TNF‐alpha.

  1994cited by this paper
• Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light

  1994cited by this paper
• Endothelin in human congestive heart failure.

  1994cited by this paper
• Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha.

  1993cited by this paper
• Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.

  1993influential reference
• Molecular phenotype of the hypertrophied and failing myocardium

  1993cited by this paper
• Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.

  1993cited by this paper
• Structural basis for changes in left ventricular function and geometry because of chronic mitral regurgitation and after correction of volume overload.

  1993cited by this paper
• Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium.

  1993cited by this paper
• Negative inotropic effects of cytokines on the heart mediated by nitric oxide.

  1992cited by this paper
• Adrenergic Effects on the Biology of the Adult Mammalian Cardiocyte

  1992cited by this paper
• Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs.

  1992cited by this paper
• The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure.

  1992cited by this paper
• Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction.

  1992cited by this paper
• Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output.

  1992cited by this paper
• Relation between ventricular and myocyte remodeling with the development and regression of supraventricular tachycardia-induced cardiomyopathy.

  1991cited by this paper
• Endothelin Has Biological Actions at Pathophysiological Concentrations

  1991cited by this paper
• Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.

  1991cited by this paper
• Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia.

  1991cited by this paper
• Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

  1990influential reference
• TNF-induced cardiomyopathy.

  1990cited by this paper
• Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

  1989cited by this paper
• The cardiovascular response of normal humans to the administration of endotoxin.

  1989cited by this paper
• Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock

  1989cited by this paper
• Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome.

  1989cited by this paper
• Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness.

  1989cited by this paper
• Chronic TNF Infusion Causes Anorexia But Not Accelerated Nitrogen Loss

  1989cited by this paper
• Continuous infusion of tumor necrosis factor: mechanisms of toxicity in the rat.

  1988cited by this paper
• Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.

  1988cited by this paper
• Recombinant human tumor necrosis factor induces acute reductions in food intake and body weight in mice

  1988cited by this paper
• Inadequate collagen tethers in dilated cardiopathy.

  1988cited by this paper
• Tumor necrosis factor provokes superoxide anion generation from neutrophils.

  1986cited by this paper
• Morphometric analysis of biologic processes.

  1984cited by this paper
• Regional Myocyte Size in Normotensive and Spontaneously Hypertensive Rats

  1979cited by this paper
• Density and composition of mammalian muscle

  1960cited by this paper

• From Single Cells to Targetable Immune Mechanisms in Congenital Heart Disease, Ischemic Heart Disease, and Abdominal Aortic Aneurysm.

  2026cites this paper
• IL-22 Attenuates Pressure Overload-Induced Heart Failure and Inflammation

  2025cites this paper
• An atypical multiple autoimmune syndrome: A case report including myocarditis

  2025cites this paper
• Association between inflammatory burden index and risk of heart failure: evidence from NHANES 2003–2017

  2025cites this paper
• Molecular mechanisms and complications of TNF blockade in heart failure: targeting signalling and genetic determinants of therapeutic response

  2025cites this paper
• Exercise Training in Heart Failure: Clinical Benefits and Mechanisms.

  2025cites this paper
• The Gut–Heart Axis and Its Role in Doxorubicin-Induced Cardiotoxicity: A Narrative Review

  2025cites this paper
• Heart failure decompensation with cardiogenic shock exhibits distinct sequential inflammatory profiles

  2025cites this paper
• Loganic acid ameliorates diabetic cardiomyopathy via suppressing TLR4/p38 MAPK signaling-mediated oxidative stress and inflammation

  2025cites this paper
• Infection in people with heart failure: an overlooked cause of adverse outcomes

  2025cites this paper
• Not just a witness: Highlighting the utility of witness social defeat stress for the examination of neuroimmune-cardiovascular interactions across diverse populations

  2025cites this paper
• Neuroimmune cross-talk in heart failure.

  2024cites this paper
• Rheumatoid arthritis increases the risk of heart failure: results from the cross-sectional study in the US population and mendelian randomization analysis in the European population

  2024cites this paper
• Mitochondrial Dysfunction in Heart Failure: From Pathophysiological Mechanisms to Therapeutic Opportunities

  2024cites this paper
• The role of circulating cytokines in heart failure: a bidirectional, two-sample Mendelian randomization study

  2024cites this paper
• An ImmunoFET Coupled with an Immunomagnetic Preconcentration Technique for the Sensitive EIS Detection of HF Biomarkers

  2024cites this paper
• Serial and regional assessment of the right ventricular molecular and functional response to pressure-loading.

  2024cites this paper
• Assessment of left and right ventricular systolic function in dogs with multicentric lymphoma.

  2024cites this paper
• Cardiovascular complications of rheumatoid arthritis.

  2024cites this paper
• Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

  2024cites this paper
• Immune patterns of cuproptosis in ischemic heart failure: A transcriptome analysis

  2024cites this paper
• m6A epitranscriptomic modification of inflammation in cardiovascular disease.

  2024cites this paper
• Pathogenesis of Extraarticular Manifestations in Rheumatoid Arthritis—A Comprehensive Review

  2023cites this paper
• Neuromodulation Therapies in Heart Failure: A State-of-the-Art Review

  2023cites this paper
• Systematic investigation of the multi-scale mechanisms of herbal medicine on treating ventricular remodeling: Theoretical and experimental studies.

  2023cites this paper
• Gut microbiota and integrative traditional Chinese and western medicine in prevention and treatment of heart failure.

  2023cites this paper
• Cognitive impairment in patients with heart failure: molecular mechanism and therapy

  2023cites this paper
• β-Caryophyllene, a Dietary Phytocannabinoid, Alleviates Diabetic Cardiomyopathy in Mice by Inhibiting Oxidative Stress and Inflammation Activating Cannabinoid Type-2 Receptors.

  2023cites this paper
• Inflammation, dysregulated iron metabolism, and cardiovascular disease

  2023cites this paper
• Molecular mechanisms underlying sarcopenia in heart failure

  2023cites this paper
• SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes

  2022cites this paper
• Intermittent Short-Duration Re-oxygenation Attenuates Cardiac Changes in Response to Hypoxia: Histological, Ultrastructural and Oxidant/Antioxidant Parameters

  2022cites this paper
• Role of inflammation in diabetic cardiomyopathy

  2022cites this paper
• Expression of interleukin 1, interleukin 27, and TNF α genes in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy: A case‐control study

  2022cites this paper
• The Dynamic Role of Cardiac Macrophages in Aging and Disease

  2022cites this paper
• Immunomodulatory Cell Therapy Using αGalCer-Pulsed Dendritic Cells Ameliorates Heart Failure in a Murine Dilated Cardiomyopathy Model

  2022cites this paper
• The cardioprotective effects of nano‐curcumin against doxorubicin‐induced cardiotoxicity: A systematic review

  2022cites this paper
• The Effect of Probiotic Strains on Myocardial Infarction Size, Biochemical and Immunological Parameters in Rats with Systemic Inflammatory Response Syndrome and Polymorbidity

  2022cites this paper
• Signaling Pathways in Inflammation and Cardiovascular Diseases: An Update of Therapeutic Strategies

  2022cites this paper
• Evaluating individual biomarkers for predicting health risks in zoo‐housed chimpanzees (Pan troglodytes) and bonobos (Pan paniscus)

  2022cites this paper
• Endothelial Dysfunction in Heart Failure With Preserved Ejection Fraction: What are the Experimental Proofs?

  2022cites this paper
• Pro-Inflammatory Derangement of the Immuno-Interactome in Heart Failure

  2022cites this paper
• Effects of the Dectin-2/TNF-α Pathway on Ventricular Arrhythmia after Acute Myocardial Infarction in Mice

  2022cites this paper
• In Vitro and In Vivo Cardioprotective Effects of Curcumin against Doxorubicin-Induced Cardiotoxicity: A Systematic Review

  2022cites this paper
• Potential Protective Effect of Vitamin C on Qunalphos-Induced Cardiac Toxicity: Histological and Tissue Biomarker Assay

  2021cites this paper
• Current and future therapeutic perspective in chronic heart failure.

  2021cites this paper
• Targeting Mediators of Inflammation in Heart Failure: A Short Synthesis of Experimental and Clinical Results

  2021cites this paper
• SARS-CoV-2-Induced Damage on the Cardiovascular System: Molecular Mechanisms

  2021cites this paper
• ADAM17, A Key Player of Cardiac Inflammation and Fibrosis in Heart Failure Development During Chronic Catecholamine Stress

  2021cites this paper
• Inflammation in Metabolic Cardiomyopathy

  2021cites this paper
• Age, sex, and inflammatory markers predict chronic conditions, cardiac disease, and mortality among captive western lowland gorillas (Gorilla gorilla gorilla)

  2021cites this paper
• COVID-lateral damage: cardiovascular manifestations of SARS-CoV-2 infection

  2021cites this paper
• Myeloid-Derived Growth Factor Protects Against Pressure Overload–Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca2+-ATPase Expression in Cardiomyocytes

  2021cites this paper
• Viruses in the Heart: Direct and Indirect Routes to Myocarditis and Heart Failure

  2021cites this paper
• Recent Advances in the Development of Theranostic Nanoparticles for Cardiovascular Diseases

  2021influential citation
• POTENTIAL ROLE OF GLP-1 RECEPTOR AGONIST IN A RAT MODEL OF CARDIO-RENAL SYNDROME TYPE-3: EFFECTS ON OXIDATIVE, INFLAMMATORY AND INOS EXPRESSION AXIS

  2021cites this paper
• Immune Cells and Immunotherapy for Cardiac Injury and Repair

  2021cites this paper
• Essential amino acid supplementation is associated with reduced serum C-reactive protein levels and improved circulating lymphocytes in post-acute inflamed elderly patients

  2021cites this paper
• A systematic review of biomarkers in Takotsubo syndrome: A focus on better understanding the pathophysiology

  2021cites this paper
• Comparative efficacy and safety of chimeric and recombinant anti-TNF-α mAbs

  2021cites this paper
• Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies

  2021cites this paper
• Scientific hypothesis and rational pharmacological for the use of sacubitril/valsartan in cardiac damage caused by COVID-19

  2021cites this paper
• Expression of Interleukin 1, Interleukin 27 and TNF α Genes in Patients with Ischemic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy

  2021cites this paper
• Berry-Derived Polyphenols in Cardiovascular Pathologies: Mechanisms of Disease and the Role of Diet and Sex

  2021cites this paper
• Myocardial Dysfunction and Heart Failure in Rheumatoid Arthritis

  2021cites this paper
• Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm

  2021cites this paper
• Coronary stent technology and the role of inflammation in the atherogenesis: problems and prospects

  2021cites this paper
• Metabolically Healthy, but Obese Individuals and Associations with Echocardiographic Parameters and In fl ammatory Biomarkers: Results from the CARLA Study Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

  2020cites this paper
• The gut microbiota and diabetic cardiomyopathy in humans.

  2020cites this paper
• Yangxin granules alleviate doxorubicin-induced cardiotoxicity by suppressing oxidative stress and apoptosis mediated by AKT/GSK3β/β-catenin signaling

  2020cites this paper
• Extracellular heat shock protein HSC70 protects against lipopolysaccharide-induced hypertrophic responses in rat cardiomyocytes.

  2020cites this paper
• Metabolically Healthy, but Obese Individuals and Associations with Echocardiographic Parameters and Inflammatory Biomarkers: Results from the CARLA Study

  2020cites this paper
• Heart Failure as a Consequence of Dilated Cardiomyopathy

  2020cites this paper
• Physical Exercise as an Immunomodulator of Chronic Diseases in Aging.

  2020cites this paper
• The Cardioprotective Role of Flaxseed in the Prevention of Doxorubicin- and Trastuzumab-Mediated Cardiotoxicity in C57BL/6 Mice.

  2020cites this paper
• Macrophage Activities in Myocardial Infarction and Heart Failure

  2020cites this paper
• Edaravone and benidipine protect myocardial damage by regulating mitochondrial stress, apoptosis signalling and cardiac biomarkers against doxorubicin-induced cardiotoxicity

  2020cites this paper
• The Molecular and Cellular Mechanisms Associated with a Microvascular Inflammation in the Pathogenesis of Heart Failure with Preserved Ejection Fraction

  2020cites this paper
• Macrophage Activities inMyocardial Infarction andHeart Failure

  2020cites this paper
• Mechanisms underlying the cross‐talk between heart and cancer

  2020cites this paper
• Inflammation in Heart Failure: JACC State-of-the-Art Review.

  2020cites this paper
• Proinflammatory Cytokines in Acute Coronary Syndromes.

  2020cites this paper
• Clonal Hematopoiesis: A New Step Linking Inflammation to Heart Failure

  2020cites this paper
• Bioprinting and in vitro characterization of alginate dialdehyde–gelatin hydrogel bio-ink

  2020cites this paper
• Sulforaphane Prevents Right Ventricular Injury and Reduces Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.

  2020cites this paper
• Cardiovascular effects of biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs).

  2020cites this paper
• Effect and Mechanism of Ganoderma lucidum Spores on Alleviation of Diabetic Cardiomyopathy in a Pilot in vivo Study

  2020cites this paper
• Metabolically Healthy, but Obese Individuals and Associations with Echocardiographic Parameters and In fl ammatory Biomarkers: Results from the CARLA Study Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

  2020cites this paper
• Effect and Mechanism of Ganoderma lucidum Spores on Alleviation of Diabetic Cardiomyopathy in a Pilot in vivo Study

  2020cites this paper
• TNF-α signaling: TACE inhibition to put out the burning heart

  2020cites this paper
• Reappraising the role of inflammation in heart failure

  2020cites this paper
• Mechanisms of Kidney and Heart Cross-talk in Acute Kidney Injury

  2020cites this paper
• Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide

  2020cites this paper
• Targeted anti-inflammatory therapy is a new insight for reducing cardiovascular events: A review from physiology to the clinic.

  2020cites this paper
• Findings on the relationship between cardiovascular disease and coronavirus disease 2019: a systematic review

  2020cites this paper
• Right Atrial Myocardial Remodeling in Children With Atrial Septal Defect Involves Inflammation, Growth, Fibrosis, and Apoptosis

  2020cites this paper
• Effect of atorvastatin on oxidative stress and inflammation markers in myxomatous mitral valve disease in dogs: A comparison of subclinical and clinical stages

  2019cites this paper
• The small molecule Chicago Sky Blue promotes heart repair following myocardial infarction in mice.

  2019cites this paper
• Effect of Eight Weeks Resistance Training On Gene Expression of TNF-Α and IL10 in the Heart of Type II Diabetic Male Rats

  2019cites this paper
• Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure

  2019cites this paper